Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michiels

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementH A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokersT Dutu, S Michiels, P Fouret, et al.
Public Health|June 4, 2017
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American regionJ Martínez-Mesa, G Werutsky, S Michiels, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2007
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancerL Taillade, F Penault-Llorca, T Boulet, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)C Courtinard, V Barbet, R Schiappa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancerC Criscitiello, M A Bayar, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementS Guiu, S Michiels, F André, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementH A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokersT Dutu, S Michiels, P Fouret, et al.
Public Health|June 4, 2017
Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American regionJ Martínez-Mesa, G Werutsky, S Michiels, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2007
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancerL Taillade, F Penault-Llorca, T Boulet, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)C Courtinard, V Barbet, R Schiappa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancerC Criscitiello, M A Bayar, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementS Guiu, S Michiels, F André, et al.
Pageof 6